Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Desensitization of the immune system through exposure to allergens from Dermatophagoides farinae and Dermatophagoides pteronyssinus (house dust mites) aims to reduce the immune system's hypersensitivity by gradually introducing increasing doses of specific allergens. This induces tolerance and reduces allergic symptoms, primarily by targeting mast cells, basophils, T regulatory lymphocytes, IgE, IgG4, IgA antibodies, and cytokines such as IL-10 and TGF-beta.
Desensitization of the immune system via exposure to Dermatophagoides farinae and Dermatophagoides pteronyssinus allergens involves multiple stages: early reduction of mast cell/basophil degranulation, intermediate induction of allergen-specific Tregs (secreting IL-10/TGF-beta) which suppress Th2 inflammation, and late changes in antibody production (decreased IgE, increased IgG4/IgA). IL-10 plays a central role by promoting IgE to IgG4/IgA class switching and suppressing mast cell/basophil activation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Components Mediating Allergy to Dermatophagoides farinae and Dermatophagoides pteronyssinus (N/A).